ATE273988T1 - Verfahren zur herstellung von 6-o- methylerythromycin a unter verwendung von 9- hydroxyerythromycinderativen - Google Patents

Verfahren zur herstellung von 6-o- methylerythromycin a unter verwendung von 9- hydroxyerythromycinderativen

Info

Publication number
ATE273988T1
ATE273988T1 AT98959481T AT98959481T ATE273988T1 AT E273988 T1 ATE273988 T1 AT E273988T1 AT 98959481 T AT98959481 T AT 98959481T AT 98959481 T AT98959481 T AT 98959481T AT E273988 T1 ATE273988 T1 AT E273988T1
Authority
AT
Austria
Prior art keywords
erythromycin
hydroxyerythromycin
deratives
methylerythromycin
producing
Prior art date
Application number
AT98959481T
Other languages
English (en)
Inventor
Yi-Yin Ku
David A Riley
Elaine C Lee
Jien-Heh J Tien
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE273988T1 publication Critical patent/ATE273988T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT98959481T 1997-12-16 1998-11-17 Verfahren zur herstellung von 6-o- methylerythromycin a unter verwendung von 9- hydroxyerythromycinderativen ATE273988T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/991,648 US5892008A (en) 1997-12-16 1997-12-16 Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivatives
PCT/US1998/024498 WO1999031114A1 (en) 1997-12-16 1998-11-17 Process for the preparation of 6-o-methyl erythromycin a using 9-hydroxy erythromycin derivatives

Publications (1)

Publication Number Publication Date
ATE273988T1 true ATE273988T1 (de) 2004-09-15

Family

ID=25537423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98959481T ATE273988T1 (de) 1997-12-16 1998-11-17 Verfahren zur herstellung von 6-o- methylerythromycin a unter verwendung von 9- hydroxyerythromycinderativen

Country Status (13)

Country Link
US (1) US5892008A (de)
EP (1) EP1044209B1 (de)
JP (1) JP2002508385A (de)
KR (1) KR20010033178A (de)
AT (1) ATE273988T1 (de)
AU (1) AU1526999A (de)
CA (2) CA2315209C (de)
DE (1) DE69825785T2 (de)
DK (1) DK1044209T3 (de)
ES (1) ES2229552T3 (de)
IL (1) IL136237A0 (de)
PT (1) PT1044209E (de)
WO (1) WO1999031114A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3054699B2 (ja) * 1998-08-07 2000-06-19 工業技術院長 Ｏ−シリル化含水酸基環状エーテルの製造方法
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
KR100336447B1 (ko) * 1999-11-24 2002-05-15 민경윤 클라리스로마이신의 개선된 제조방법
CZ20021999A3 (cs) * 1999-12-16 2003-02-12 Teva Pharmaceutical Industries Ltd. Způsob přípravy klaritromycinových polymorfních forem a nového polymorfu IV
PT1280535E (pt) 2000-01-11 2005-04-29 Teva Pharma Processos para a preparacao de polimorfos de claritromicina
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
WO2001064224A1 (en) * 2000-02-29 2001-09-07 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
US6605707B1 (en) 2000-03-23 2003-08-12 Abbott Laboratories Process for the preparation of 6-O-propargyl erythromycin derivatives
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
AU2004258949B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004258944B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004264939A1 (en) * 2003-08-11 2005-02-24 Middlebrook Pharmaceuticals, Inc. Robust pellet
CA2535398C (en) * 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004273830B2 (en) * 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1771158A4 (de) * 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp Tablette für pulsierte abgabe
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20090054634A1 (en) * 2007-08-09 2009-02-26 Vinod Kumar Kansal Process for the preparation of clarithromycin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
US5872229A (en) * 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives

Also Published As

Publication number Publication date
AU1526999A (en) 1999-07-05
EP1044209B1 (de) 2004-08-18
EP1044209A1 (de) 2000-10-18
DK1044209T3 (da) 2004-11-22
US5892008A (en) 1999-04-06
KR20010033178A (ko) 2001-04-25
PT1044209E (pt) 2004-11-30
ES2229552T3 (es) 2005-04-16
CA2315209A1 (en) 1999-06-24
DE69825785T2 (de) 2005-08-18
CA2615701A1 (en) 1999-06-24
WO1999031114A1 (en) 1999-06-24
DE69825785D1 (de) 2004-09-23
IL136237A0 (en) 2001-05-20
CA2315209C (en) 2008-04-08
JP2002508385A (ja) 2002-03-19

Similar Documents

Publication Publication Date Title
ATE273988T1 (de) Verfahren zur herstellung von 6-o- methylerythromycin a unter verwendung von 9- hydroxyerythromycinderativen
DK0891370T3 (da) 2'-beskyttede 3'-dimethylamin, 9-etheroxim-erythromycin A-derivater
DE69314239D1 (de) Verfahren zur Stereoselektivglycosylierung
NO171981C (no) Alkynylaminonukleotider, fremgangsmaate for fremstilling derav, 7-jodnukleotider, merkede alkynyl-aminonukleotider samt fremgangsmaate for fremstilling av 7-(3-amino-1-propynyl)-2',3'-dideoxyguanosin-5'-trifosfat
CA2279932A1 (en) 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
DK1032581T3 (da) Kemisk syntese af 6-O-alkyl-erythromycin A
ATE294809T1 (de) Verfahren zur herstellung von 6-o-alkenyl- subsitutierten erythromycin-derivativen
DE59813747D1 (de) Verfahren zum Versehen einer metallischen Oberfläche mit einer glasartigen Schicht
DE69837041D1 (de) Verfahren und mikroorganism zur herstellung von purin-nukleosiden durch fermentation
DE69109329D1 (de) Verfahren zur Herstellung einer einkristallinen Bornitridschicht.
DE69314717D1 (de) Verfahren zur Herstellung polykristalliner Siliciumcarbid-Fiber
PT693065E (pt) Derivados de cumarina nao-nucleosidicos como agentes reticulantes de polionucleotidos
DE3784123D1 (de) Verfahren zur herstellung keramischer verbundwerkstoffe.
DE69828692D1 (de) Kristalline macrolide und verfahren zu ihrer herstellung
WO2000061594A3 (de) Nucleosid-derivate mit photolabilen schutzgruppen
DE3770000D1 (de) Makrolid-derivate, verfahren zu ihrer herstellung und ihre verwendung.
DE69609797D1 (de) Formkörper aus pyrolytischem Bornitrid und Verfahren zu seiner Herstellung
ATE199724T1 (de) Verfahren zur herstellung von 1-(2'-desoxy-2',2'- difluoro-d-ribo-pentofuranosyl)-cytosin aus 2- desoxy-2,2-difluoro-beta-d-ribo-pentopyranose
DE3679672D1 (de) Verfahren zur herstellung gesinterter siliziumcarbidartikel hoher dichte.
DE68907934D1 (de) Verfahren zur herstellung von 4-demethoxydaunomycinon, das aglycon von 4-demethoxydaunorubicin.
DE60205377D1 (de) Verfahren zur arylierung von funktionalisierten o-allyl erythromycin derivaten
DE59203001D1 (de) Verfahren zur Herstellung einer monokristallinen Siliciumcarbid-Schicht.
ATE233781T1 (de) Neue polyenantibiotika 3874 h1 bis h6, verfahren zu ihrer herstellung und verwendung
PT88952A (pt) Processo para a preparacao de avermectinas etiladas
DE3678672D1 (de) Verfahren zur herstellung siliziumkarbidkoerpern.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1044209

Country of ref document: EP

REN Ceased due to non-payment of the annual fee